Work

Fluorine-containing drugs approved by the FDA in 2021

Year: 2022

Type: article

Source: Chinese Chemical Letters

DOI: 10.1016/j.cclet.2022.06.001

Authors: Jingrui He, Ziyi Li, Gagan Dhawan, Wei Zhang, Alexander E. Sorochinsky, Greg Butler, Vadim A. Soloshonok, Jianlin Han

Institutions: Nanjing Forestry University, University of Delhi, University of Massachusetts Boston, National Academy of Sciences of Ukraine, Institute of Bioorganic Chemistry and Petrochemistry V.P. Kukhar, Ikerbasque, University of the Basque Country

Language: English

Topic: Fluorine in Organic Chemistry

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Ikerbasque, Basque Foundation for Science, Qinglan Project of Jiangsu Province of China

Award: G7034487035

OpenAlex ID: W4281781938

FWCI: 12.61

Cites: 125

Cited by: 173

Related to: 10